Clinical Trial Update: Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting [Phase 3]

View source ↗

Summary

This update covers a Phase 3 trial comparing topiramate added to placebo for outpatients with bipolar disorder, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Ortho-McNeil Neurologics, Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED